Dr. Etsubdenk Mezemir Ajebo, MD

Dr. Ajebo practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Ajebo's NPI, 1134788532, was assigned on June 10, 2019. Dr. Ajebo graduated from Medical College of Georgia School of Medicine in 2019. Dr. Ajebo holds Maryland license 7730D97154.

Dr. Ajebo's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Ajebo's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. The medical group on file is MedStar Washington Hospital Center. Dmand AI also links Dr. Ajebo to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ajebo practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ajebo's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ajebo is licensed in Maryland.

CMS data shows 840 Medicare services from Dr. Ajebo across 12 procedure codes in 2024, for 267 Medicare patients. Medicare paid $55,822 for them. Every service was in an office.

CMS counts 267 Medicare patients who saw Dr. Ajebo in 2024. The largest group is 65 to 74, with 135 patients. 68% of them have high cholesterol, and 60% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ajebo's median patient age at 44, with 63% women.

In 2024, Dr. Ajebo wrote 350 Medicare Part D claims for 99 patients. 78% of them were for generic drugs. CMS names the drug for 246 of them, across 11 drugs with 11 or more claims each, at $172,762 in total drug cost. In 2023, CMS named 83 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ajebo for performance year 2024, reported as part of a group. Dr. Ajebo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of removal of skin lesions by Dr. Ajebo, more than 69% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Ajebo, published from 2019 to 2023. 2022 was the busiest year, with 2. Dr. Ajebo has published most often in JAAD Case Rep. Dr. Ajebo's most frequent co-authors are Loretta S. Davis, MD, Matthew Belcher, MD and Vivek Choudhary, MD.

CMS Open Payments shows 67 general payments to Dr. Ajebo from 17 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $460.

Dr. Ajebo graduated from Medical College of Georgia School of Medicine in 2019.